在本篇論文中，我們研究在哺乳細胞中的TPX II會受到亞砷酸鈉的調節且TPX II會與亞砷酸鈉鍵結。先前我們實驗室已經證實，TPX II蛋白會過量表現於中國倉鼠卵巢抗砷細胞株SA7中(SA7細胞是持續培養在含有亞砷酸鈉的培養液中)。在本研究中，利用定量聚合酶連鎖反應及西方點墨法，探討亞砷酸鈉影響TPX II基因及蛋白表現的情形。由結果發現，三價砷確實會誘發TPX II基因及蛋白的表現，且呈現時間相關性。為了更進一步確定，在亞砷酸鈉所誘發的毒性中，TPX II所具有的生理功能，將TPX II 轉植株細胞 (KB-TPX及3T3-TPX)處理亞砷酸鈉 (Sodium arsenite)和過氧化氫 (H2O2)。結果發現，轉植株細胞KB-TPX較能抵抗過氧化氫的毒性，而對亞砷酸鈉的毒性則較無抗性。最近的結果亦顯示，在大腸桿菌系統中表現的TPX II蛋白和SA7細胞中的TPX II蛋白，能直接與亞砷酸鈉產生鍵結。亞砷酸鈉已被提及對蛋白質的硫醇基有高度親和性。因此目前利用在TPX II蛋白的半胱胺酸進行點突變，以期能更進一步確定三價砷與TPX II蛋白鍵結的主要胺基酸位置。

Previously our laboratory has identified that TPX II protein was overexpressed in SA7 cells (an arsenic resistant cell routinely cultured in arsenite-containing medium). In this study, the effect of As3+ on the TPX II gene and protein expression were further explored by quantitative PCR and Western blotting analysis. The results showed that arsenite induced TPX II gene and protein expression in a time-dependent manner. To identify the physiological function of TPX II in arsenite-induced toxicity, the TPX II-transfected KB (KB-TPX) and 3T3 (3T3-TPX) cells were treated with sodium arsenite and hydrogen peroxide (H2O2). The results showed that KB-TPX cells exhibits more resistant to H2O2, but not sodium arsenite. The current results also show that sodium arsenite bind directly to TPX II in E.coli expression system and in SA7 cells. Arsenite has been proposed with high affinity for sulfhydryl groups of protein. Therefore, site-directed mutagenesis in cysteine residues of TPX II are currently underway to further identify the binding site of TPX II with arsenite.

Aposhian, H. V. 1989. Biochemical toxicology of arsenic.　Rev.Biochem.Toxicol.10:265-99.
Applegate, L. A., P. Lushcher, and R. M. Tyrrell 1991. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res.51:974-78.
Berolero, F., G. Pozzi, E. Sabbioni, and U. Saffiotti 1987. Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation.　Carcinogenesis.8:803-8.
Bhattacharjee, H., and B. P. Rosen 1996. Spatial proximity of Cys113, Cys172, and Cys422 in the metalloactivation domain of the ArsA ATPase. J. Biol. Chem.271:24465-70.
Bogdan, G. M., A. Sampayo-Reyes, and H. V. Aposhian 1994. Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver. Toxicology.93:175-93.
Buchet, J. P., and R. Lauwerys 1985. Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observation in man. Arch. Toxicol.57:125-9.
Carlson-Lynch, H., B. D. Beck, and P. D. Boardman 1994. Arsenic risk assessment.Environ. Health Perspect.102:354-56.
Chae, H. Z., H. J. Kim, S. W. Kang, and S. G. Rhee 1999. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes. Res. Clin. Pract.45:101-112.
Chae, H. Z., I. H. Kim, K. Kim, and S. G. Rhee 1993. Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J. Biol. Chem.268:16815-21.
Chae, H. Z., S. J. Kim, S. W. Chung, and S. G. Rhee 1994. Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem.269:27670-78.
Chae, H. Z., K. Robison, L. B. Poole, G. Church, and S. G. Rhee 1994. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc. Natl. Acad. U.S.A.91:7017-7021.
Chen, C. J., Y. C. Chuang, T. M. Lin, and H. Y. Wu 1985. Malignant neoplasms among residents of a blackfoot diease-endemic area in Taiwan: hight-arsenic artesian well water and cancers. Cancer Res.45:5895-9.
Chen, C. J., Y. M. Hsueh, M. S. Lai, M. P. Shyu, S. Y. Chen, M. M. Wu, T. L. Kuo, and T. Y. Tai 1995. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension.25:53-60.
Chen, G. Q., J. Zhu, X. G. Shi, J. H. Ni, H. J. Zhong, G. Y. Si, X. L. Jin, W. Tang, X. S. Li, S. M. xong, Z. X. Shen, G. L. Sun, J. Ma, P. Zhang, T. D. Zhang, C. Gazin, T. Naoe, S. J. Chen, Z. Y. Wang, and Z. Chen 1996. In virto studies on cellular and molecular mechanisms of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia:As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood.88:1052-61.
Chen, H. Z., I. H. Kim, K. Kim, and S. G. Rhee 1993. Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J. Biol. Chem.268:16815-21.
Chen, M. L., R. S. King, and H. J. Armbrecht 1990. Sodium-dependent phosphate transport in primary cultures of renal tubule cells from young and adult rats. J. Cell. Physiol.143:488-93.
Crecelius, E. A. 1977. Changes in the chemical speciation of arsenic following ingestion by man. Environ. Health Perspect.19:147-50.
Del Razo, L. M., M. A. Arellano, and M. E. Cebrian 1990. The oxidation states of arsenic in well-water from a chronic arsenicism of Northern Mexico. Environ. Pollut.64:143-53.
Delnomdedieu, M., M. M. Basti, J. D. Otvos, and D. J. Thomas 1994. Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study. Chem. Biol. Interact.90:139-55.
Fan, S. R., I. C. Ho, F. L. Yeoh, C. J. Lin, and T. C. Lee 1996. Squalene inhibits sodium arsenite-induced sister chromatid exchanges and micronuclei in Chinese hamster ovary-K1 cells. Mutat. Res,.368:165-9.
Fischer, A. B., J. P. Buchet, and R. Lauwerys 1985. Arsenic uptake, cytotoxicity and detoxification studied in mammalian cells in culture. Arch. Toxicol.57:168-72.
Gorbsky, G. J. 1994. Arsenic in human medicine, arsenic in the environment.Part2: Human health and ecosystem effects, New York.
Gurley, L. R., R. A. Walters, J. H. Jett, and R. A. Tobey 1980. Response of CHO cell proliferation and histone phosphorylation to sodium arsenite. J. Toxicol. Environ. Health.6:87-105.
Huang, R. N., and T. C. Lee 1996. Cellular uptake of trivalent arsenite and pentavalent arsenate in KB cells cultured in phosphate-free medium. Toxicol.Appl. Pharmacol.136:243-9.
IARC. 1980. Carcinogenesis of arsenic and arsenic compounds. IARC.23:37-141.
Ishii, T., M. Yamada, H. Sato, M. Matsue, S. Taketani, K. Nakayama, Y. Sugita, and S. Bannai 1993. Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J. Biol. Chem.268:18633-36.
Ishinishi, N., A. Yamamoto, A. Hisanaga, and T. Inamasu 1983. Tumorigenicity of arsenic trioxide to the lung in syrian golden hamsters by intermittent instillations. Cancer Lett.21:141-7.
Ivhimiya, S., J. G. Davis, D. M. O''rourke, M. Katsumata, and M. I. Greene 1997. Murine Thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury. DNA Cell Biol.16:311-21.
Iwahara, S., H. Satoh, D. X. Song, J. Webb, A. L. Burlingame, Y. Nagae, and U. Muller-Eberhard 1995. Purification, characterization, and cloning of a heme-binding protein (23 kDa) in rat liver cytosol. Biochemistry.34:13398-406.
Jin, D. Y., H. Z. Chae, S. G. Rhee, and K. T. Jeang 1997. Regulatory role for a novel human thioredoxin peroxidase in NF-?B Activation. J. Biol. Chem.272:30952-61.
Kang, S. W., I. C. Baines, and S. G. Rhee 1998. Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J. Biol. Chem.273:6303-11.
Kang, S. W., H. Z. Chae, M. S. Seo, K. Kim, and I. C. Baines 1998. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-a. J. Biol. Chem.273:6297-02.
Kawai, S., S. Takeshita, M. Okazaki, R. Kikuno, A. Kudo, and E. Amann 1994. Cloning and characterization of OSF-3, a new member of the MER5 family, expressed in mouse osteoblastic cells. J. Biochem.115:641-3.
Knowles, F. C., and A. A. Benson 1983. The biochemistry of arsenic. Trends Biochem. Sci.8:178-180.
Lee, T. C., and I. C. Ho 1995. Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts. Arch. Toxicol.69:498-504.
Lee, T. C., M. Oshimura, and J. C. Barrett 1985. Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in syrian hamster embryo cells in culture. Carcinogenesis.6:1421-26.
Lee, T. H., S. L. Yu, S. U. Kim, Y. M. Kim, I. Choi, S. W. Kang, S. G. Rhee, and D. Y. Yu 1999. Characterization of the murine gene encoding 1-Cys peroxiredoxin and identification of highly homologous genes. Gene.234:337-344.
Lee, T. H., S. L. Yu, S. U. Kim, K. K. Lee, S. G. Rhee, and D. Y. Yu 1999. Characterization of mouse peroxiredoxin I genomic DNA and its expression. Gene.239:243-250.
Li, W., and I. N. Chou 1992. Effects of sodium arsenite on the cytoskeleton and cellular glutathione levels in cultured cells. Toxicol.Appl. Pharmacol.114:132-9.
Lim, Y. S., M. K. Cha, C. H. Yun, H. K. Kim, K. Kim, and I. H. Kim 1994. Purification and characterization of thiol-specific antioxidant protein from human red blood cell: A new type of antioxidant protein. Biochem. Biophysiol. Res. Commun.199:199-206.
Liu, Y. C., and H. Huang 1997. Involvement of calcium-dependent protein kinase C in arsenite-induced genotoxicity in Chinese hamster ovary cells. J. Cell Biochem.64:423-33.
Lynn, S., J. N. Shiung, J. R. Gurr, and K. Y. Jan 1998. Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide. Free Radic. Biol. Med.24:442-9.
Mann, S., P. O. Droz, and M. Vahter 1996. Physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans. Toxicol.Appl. Pharmacol.140:471-86.
Menzel, D. B., H. K. Hamadeh, E. Lee, D. M. Meacher, V. Said, R. E. Rasmussen, H. Greene, and R. N. Roth 1999. Arsenic binding proteins from human lymophoblastoid cells. Toxicol. Lett.105:89-101.
Mizusawa, H., T. Ishii, and S. Bannai 2000. Perosiredoxin I (macrophage 23 kDa stress protein ) is highly and widely expression in the rat nervous system. Neurosci. Lett.283:57-60.
Morton, W. E., and D. A. Dunnette 1994. Health effect of environmental arsenic. In Arsenic in the environment, New York.
Prosperi, M. T., D. Ferbus, I. Karczinski, and G. Goubin 1993. A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins. J. Biol. Chem.268:11050-56.
Prosperi, M. T., D. Ferbus, D. Rouillard, and G. Goubin 1998. The pag gene product, a physiological inhibitor of c-abl tyrosine kinase, is overexpressed in cells entering S phase and by contact with agents inducing oxidative stress. FEBS Lett.423:39-44.
Schroder, E., J. A. Littlechild, A. A. Lebedev, N. Errington, A. A. Vagin, and M. N. Isupov 2000. Crystal structure of decameric 2-Cys peroxiredoxin from human erythrocytes at 1.7A resolution. Structure.8:605-15.
Scott, N., K. M. Hatlelid, N. E. MacKenzie, and D. E. Carter 1993. Reaction of arsenic(III) and arsenic(V) species with glutathione. Chem.Res.Toxicol.6:102-6.
Shau, H., L. H. Butterfield, R. Chiu, and A. Kim 1994. Cloning and sequencing analysis of candidate human natural killer-enhancing factor genes. Immunogenetics.40:129-34.
Shau, H., A. C. J. Huang, M. Faris, and R. Nazarian 1998. Thioredoxin peroxidase (Natural killer Enhancing factor) regulation of activator protein-1 function in endothelial cells. Biochem. Biophysiol. Res. Commun.249:683-86.
Sheehy, J. W., and J. H. Jones 1993. Assessment of arsenic exposures and controls in gallium arsenide production. Am. Ind. Hyg. Assoc. J.54:61-9.
Shi, W., J. Dong, R. A. Scott, M. Y. Ksenzenko, and B. P. Rosen 1996. The role of arsenic-thiol interactions in metalloregulation of the ars operon.J. Biol. Chem.271: 9291-97.
Styblo, M., and D. J. Thomas 1997. Binding of arsenicals to proteins in an in vitro methylation system. Toxicol. Appl. Pharmacol.147:1-8.
Sunderman, F. W. 1979. Mechanism of metal carcinogens. Biol. Trace. Elem. Res.1:53-86.
Tseng, C. H., C. K. Chong, C. J. Chen, and T. Y. Tai 1996. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis.120:125-33.
Tseng, W. P. 1977. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic.Environ. Health. Perspect.19:109-19.
Tseng, W. P., H. M. Chu, S. W. How, J. M. Fong, C. S. Lin, and S. Yeh 1968. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst.40:453-63.
Vahter, M., and J. Envall 1983. In vivo reduction of arsenate in mice and rabbits. Environ. Res.32:14-24.
Wang, T. S., C. F. Kuo, K. Y. Jan, and H. Huang 1996. Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J. Cell. Physiol.169:256-68.
Watabe, S., H. Kohno, H. Kouyama, T. Hiroi, N. Yago, and T. Nakazawa 1994. Purification and characterization of a substrate protein for mitochondrial ATP-dependent protease in bovine adrenal cortex. J. Biochem.115:648-54.
Wen, S. T., and R. A. Van Etten 1997. The pag gene product, a stress-induced protein with antioxidant properties, is an Abl SH-3 binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes. Dev.11:2456-67.
Wen, W. N., T. L. Lieu, H. J. Chang, S. W. Wuu, M. L. Yau, and K. Y. Jan 1981. Baseline and sodium arsenite-induced sister chromatid exchange in cultured lympocytes from patients with Blackfoot disease and healthy persons. Hum. Genet.59:201-3.
Yamamoto, T., Y. Matsui, S. Natori, and M. Obinata 1989. Cloning of a housekeeping-type gene (MER5) preferentially expressed in murine erythroleukemia cells. Gene.80:337-43.
Yamanaka, K., A. Hasegawa, R. Sawamura, and S. Okada 1991. Cellular response to oxidative damage in lung induced by the administration of dimethylarsenic acid, a major metabolite of inorganic arsenics, in mice. Toxicol. Appl. Pharmacol.108:205-13.
Yanagawa, T., T. Ishikawa, T. Ishii, K. Tabuchi, S. Iwasa, S. Bannai, K. Omura, H. Suzuki, and H. Yoshida 1999. Peroxiredoxin I expression in human thyroid tumors. Cancer Lett.145:127-32.
Yanagawa, T., S. Iwasa, T. Ishii, K. Tabuchi, H. Yusa, K. Onizawa, K. Omura, H. Harada, H. Suzuki, and H. Yoshida 2000. Peroxiredoxin I expression in oral cancer: a potential new tumor marker. Cancer Lett.156:27-35.
Yih, L. H., and T. C. Lee 1999. Effects of exposure protocols on induction of kinetochore-plus and -minus micronuclei by arsenite in diploid human fibroblasts. Mutat. Res.440:75-82.
Zhang, P., B. Liu, S. W. Kang, M. S. Seo, S. G. Rhee, and L. M. Obeid 1997. Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J. Biol. Chem.272:30615-18.